Table 1.
Disease model | Name of Studied Gene | Expression Change of Studied gene | Immune Cells of Infiltration | Inflammatory Molecules | Signaling | Cardiac/Vascular Effects | Ref. |
---|---|---|---|---|---|---|---|
Viral Myocarditis | CARD9 | not mentioned | not mentioned | IFN-γ, IL-6, TGF-β, IL-17A | not mentioned | CARD9 KO ameliorated myocardial inflammation and injury. | 10 |
Cardiac Arteritis | CARD9 | not mentioned | monocytes neutrophils |
IL-1β CCL2/MCP-1, CXCL-1 |
Dectin2/CARD9/NLRP3 | CARD9 KO mice were completely protected from CAWS-induced vasculitis. | 39 |
Atherosclerosis | CARD9 | not mentioned | macrophages | MCP-1 | not mentioned | Hematopoietic CARD9 KO increased severity of plaque and lesion size. | 46 |
Atherosclerosis | CARD9 | not mentioned | macrophages CD3-positive cells |
none | not mentioned | Hematopoietic CARD9 KO did not affect lesion size. | 47 |
M-I/R Injury | CARD9 | not mentioned | neutrophils | TNF-α, IL-6, CXCL-1, MCP-1 |
p38 MAPK | CARD9 KO decreased myocardial infarct size. | 11 |
M-I/R Injury | CARD9 | upregulation | NA | NA | CARD9/Rubicon | CARD9 KO impaired autophagy and increased cardiac dysfunction. | 49 |
M-I/R Injury | CARD9 | upregulation | NA | NA | CARD9/Apaf-1 | CARD9 knockdown increased the apoptotic rate of H9C2 cells in vitro and aggravated cardiomyocytes apoptosis in vivo. | 50 |
Ang II-induced Cardiac Injury | CARD9 | upregulation | macrophages | IL-1β, TGF-β, CTGF | p38 MAPK NF-κB |
CARD9 KO decreased cardiac inflammation and fibrosis. | 12 |
Obesity-induced Cardiac Injury | CARD9 | upregulation | macrophages | IL-6, TNF-a, IL-1β | p38 MAPK | CARD9 KO increased cardiac autophagy and decreased cardiac fibrosis and dysfunction. | 44 |
Hypertension (Transverse Aortic Constriction-induced) |
CARD9 | not mentioned | not mentioned | not mentioned | NF-κB | CARD9 KO mice increased cardiac autophagy and did not develop cardiac fibrosis, hypertrophy, and dysfunction. | 43 |